In the Media

Health columnist Diane Atwood writes in her popular “Catching Health” column about new research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., on the causes of glucose-induced peripheral neuropathy, which causes pain, tingling and numbness in the hands and feet. Her research could one day lead to a cure for this potentially disabling condition, which affects millions of diabetics worldwide.

This TV segment explores a new mobile app developed by Anecdata.org, a tech startup being incubated on the campus of the MDI Biological Laboratory. The new app helps citizen scientists from around the world to easily gather, analyze and share environmental data from the field.

WABI TV5/The CW interviews Jane Disney, Ph.D., leader of the the MDI Biological Laboratory team that developed the new Anecdata.org mobile app, and other members of the team. The mobile app is a  tool that allows citizen scientists to easily collect, analyze and share environmental data from the field. The app helps inform decision-making about human impacts on the environment and other serious public issues.

New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy also plays a role in peripheral neuropathy caused by diabetes.

New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy also plays a role in peripheral neuropathy caused by diabetes.

New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy also plays a role in peripheral neuropathy caused by diabetes.

The significance of the identification of a common molecular mechanism is that many more patients could potentially benefit from drugs that target this me…

MDI Biological Laboratory on Mount Desert Island has been awarded a patent on a tiny molecule called MSI-1436. This is a big deal for two reasons: 1. It’s a first for MDI. 2. It paves the way for a possible drug that would repair and regenerate damaged heart tissue.

The MDI Biological Laboratory (Bar Harbor, Maine, USA) has announced that it will offer a one-week intensive course, May 27–June 2 2018, entitled “Applications of Organoid Technology”, in partnership with Hubrecht Organoid Technology (The HUB), a n…

This week, C What’s On radio welcomed Jeri Bowers, MDI Biological Laboratory’s Director of Development and Public Affairs, who spoke about some exciting developments in the field of regenerative medicine.

This article from the Maine Policy review explores the role of Anecdata.org, an innovative platform for citizen science projects to collect, manage and share environmental data developed by MDI Biological Laboratory faculty and staff, in providing the actionable data to effect environmental improvements.